Diabetes Mellitus Type 2 (T2DM)
8 clinical trials · Condition
◉ Watch Diabetes Mellitus Type 2 (T2DM)
| Record | Firm | Date |
|---|---|---|
| Empagliflozin as a Modulator of Systemic Vascular Resistance and Cardiac Output in Patients With Type 2 Diabetes (NCT03132181) | RWTH Aachen University | 2017-04-24 |
| Effect of Linagliptin on Vascular Inflammation in Patients With Type 2 Diabetes Mellitus (NCT02077309) | RWTH Aachen University | 2014-08-01 |
| Diastolic Dysfunction in Patients With Type 2 Diabetes Mellitus (NCT01888796) | RWTH Aachen University | 2013-09-01 |
Track Diabetes Mellitus Type 2 (T2DM) automatically
Every clearance here is in the API, with alerts when new ones post.